P. M. Mulendele, M. Njie, M. B. Charfo, G. M. Lukifimpa, M. S. Boutar, B. E. Ovaga, M. HABOUB, S. AROUS, M. G. Benouna, A. DRIGHIL, L. Azzouzi & R. HABBAL·Cardiology and Angiology: An International Journal·2023
The emergence of immunotherapy and the gradual expansion of its indications in oncology will require particular vigilance to detect and quickly take care of the potential cardiac toxicities. They have improved prognosis and survival, including patients with kidney, lung or skin c...
Open access
Research Article10.9734/ca/2023/v12i4360
Drugs used to treat cardiovascular disease as well as those used in the treatment of multiple other conditions can occasionally produce exaggerated prolongation of the QT interval on the surface electrocardiogram and the morphologically distinctive polymorphic ventricular tachyca...
Open access
Research Article10.9734/ca/2023/v12i3327
M. Njie, H. Bendahou, P. M. Mulendele, M. B. Charfo, M. HABOUB, S. AROUS, M. Ghali Benouna, A. DRIGHIL, L. Azouzi & R. HABBAL·Asian Journal of Cardiology Research·2022
Rheumatic mitral stenosis (MS) remains the most common type of valvular heart disease worldwide. While the prevalence of mitral valve rheumatism is decreasing in industrialized countries, it continues to be endemic in most countries in Asia, Latin America, the Middle East and Afr...